• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全球及各国 1990 年至 2019 年动脉粥样硬化负担变化趋势分析:基于 2019 年全球疾病负担研究结果

Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019.

机构信息

Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing 100053, China.

Department of Cardiology, Longyan First Affiliated Hospital of Fujian Medical University, Longyan, Fujian 364000, China.

出版信息

Chin Med J (Engl). 2023 Oct 20;136(20):2442-2450. doi: 10.1097/CM9.0000000000002839. Epub 2023 Sep 5.

DOI:10.1097/CM9.0000000000002839
PMID:37677929
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10586830/
Abstract

BACKGROUND

Atherosclerosis-related diseases represent significant health issues among adults globally. Despite their widespread impact, comprehensive data concerning the global and national burden and trends of these diseases remain sparse. Our objective is to examine the trends in the burden of atherosclerosis among adults from 1990 to 2019 at both global and national levels.

METHODS

We reported the average annual percentage changes (AAPCs) in prevalence, incidence, mortality, and disability-adjusted life years (DALYs) of atherosclerosis-related diseases (ischemic heart disease [IHD], ischemic stroke, and peripheral arterial disease [PAD]) at the global and national levels among individuals based on a trend analysis of the Global Burden of Diseases Study (GBD) 2019. We further analyzed these global trends as a function of age, gender, and the social development index. We also used joinpoint regression analysis to identify the year with the most substantial changes in global trends.

RESULTS

Globally, the AAPC of IHD incidence rose from 1990 to 2019 (0.20; 95% confidence interval [CI], 0.12-0.28), with substantial surges in 1995, 2001, 2005, 2010, and 2017. Conversely, AAPC of IHD mortality rates exhibited a different trend until a rise in 2014. The AAPC of incidence rates of ischemic stroke and PAD also escalated during the same period, with respective 0.43 (95% CI, 0.39-0.48) and 0.13 (95% CI, 0.06-0.21). For ischemic stroke, both incidence and mortality soared in 2014, while PAD incidence declined in 1994 and 1998, then sharply climbed in 2016. Nationally, the Northern Mariana Islands experienced the steepest increase in IHD and PAD incidence and mortality between 1990 and 2019. China saw a significant rise in ischemic stroke incidence, whereas the highest mortality rate increase occurred in Timor-Leste. By sociodemographic index (SDI) quintile, low-middle-, middle-, and high-middle-SDI countries all showed upward trends in IHD, ischemic stroke, and PAD incidence. Simultaneously, IHD and ischemic stroke mortality rates, as well as DALYs, dropped in the low-, high-middle-, and high-SDI nations. However, PAD mortality rates and DALYs saw an uptick across all SDI quintiles. Regarding age demographics, a global decrease in the AAPC IHD incidence as noted in individuals above 55 years old, in contrast to an increase in the 20-55 age group during this period. AAPC of mortality rates for IHD, ischemic stroke, and PAD decreased across all ages. The AAPC showed an increase in IHD incidence in both genders. Conversely, IHD's DALYs saw a reduction in both males and females. Ischemic stroke patterns mirrored these trends, whereas all measures for PAD exhibited growth for both sexes.

CONCLUSIONS

From 1990 to 2019, there was an overall increasing trend in the global incidence of all three clinical manifestations of atherosclerosis. Between 1990 and 2019, both the mortality rate and DALYs for IHD and ischemic stroke declined across all age groups. Overall, the burden of atherosclerosis-related diseases has not significantly decreased and even shows signs of trending upward. These findings strongly suggest that despite some progress made, efforts to control atherosclerosis diseases globally need to be intensified.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/c067b178a068/cm9-136-2442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/b7f4ed64042b/cm9-136-2442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/4b2786cad27f/cm9-136-2442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/c067b178a068/cm9-136-2442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/b7f4ed64042b/cm9-136-2442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/4b2786cad27f/cm9-136-2442-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/53fd/10586830/c067b178a068/cm9-136-2442-g003.jpg
摘要

背景

动脉粥样硬化相关疾病是全球成年人面临的重大健康问题。尽管这些疾病的影响广泛,但关于它们在全球和国家层面的负担和趋势的全面数据仍然很少。我们的目的是研究 1990 年至 2019 年期间全球和国家层面成年人动脉粥样硬化负担的趋势。

方法

我们根据 2019 年全球疾病负担研究(GBD)的趋势分析,报告了基于个体的动脉粥样硬化相关疾病(缺血性心脏病[IHD]、缺血性卒中和外周动脉疾病[PAD])的患病率、发病率、死亡率和残疾调整生命年(DALYs)的全球和国家层面的平均年百分比变化(AAPC)。我们进一步分析了这些全球趋势,包括年龄、性别和社会发展指数。我们还使用联合点回归分析确定了全球趋势变化最大的年份。

结果

全球范围内,IHD 发病率的 AAPC 从 1990 年上升至 2019 年(0.20;95%置信区间[CI],0.12-0.28),1995 年、2001 年、2005 年、2010 年和 2017 年有明显上升。相反,IHD 死亡率的 AAPC 趋势在 2014 年之前有所下降。同期,缺血性卒中和 PAD 的发病率也呈上升趋势,分别为 0.43(95%CI,0.39-0.48)和 0.13(95%CI,0.06-0.21)。对于缺血性卒,发病率和死亡率在 2014 年都飙升,而 PAD 的发病率在 1994 年和 1998 年下降,然后在 2016 年急剧上升。在国家层面,北马里亚纳群岛在 1990 年至 2019 年期间经历了 IHD 和 PAD 发病率和死亡率的最大增长。中国缺血性卒的发病率显著上升,而东帝汶的死亡率上升幅度最大。按社会发展指数(SDI)五分位数,中低、中、高-中 SDI 国家的 IHD、缺血性卒和 PAD 的发病率都呈上升趋势。同时,IHD 和缺血性卒的死亡率以及 DALYs 在低、高-中、高 SDI 国家下降。然而,所有 SDI 五分位数的 PAD 死亡率和 DALYs 都有所上升。在年龄方面,55 岁以上人群的 IHD 发病率 AAPC 呈全球下降趋势,而在此期间 20-55 岁年龄组的发病率则呈上升趋势。IHD、缺血性卒和 PAD 的死亡率的 AAPC 呈全球下降趋势。IHD 的发病率在所有性别中都呈上升趋势。相反,IHD 的 DALYs 在男性和女性中都有所减少。缺血性卒的模式与之相似,而 PAD 的所有措施在男女中均呈现增长。

结论

从 1990 年到 2019 年,全球所有三种动脉粥样硬化临床表现的发病率呈总体上升趋势。1990 年至 2019 年期间,所有年龄组的 IHD 和缺血性卒的死亡率和 DALYs 均有所下降。总的来说,动脉粥样硬化相关疾病的负担并没有显著减少,甚至有上升的趋势。这些发现强烈表明,尽管取得了一些进展,但仍需要加强全球控制动脉粥样硬化疾病的努力。

相似文献

1
Global and national burden of atherosclerosis from 1990 to 2019: trend analysis based on the Global Burden of Disease Study 2019.全球及各国 1990 年至 2019 年动脉粥样硬化负担变化趋势分析:基于 2019 年全球疾病负担研究结果
Chin Med J (Engl). 2023 Oct 20;136(20):2442-2450. doi: 10.1097/CM9.0000000000002839. Epub 2023 Sep 5.
2
Global, regional, and national epidemiology of ischemic heart disease among individuals aged 55 and above from 1990 to 2021: a cross-sectional study.1990年至2021年55岁及以上人群缺血性心脏病的全球、区域和国家流行病学:一项横断面研究。
BMC Public Health. 2025 Mar 12;25(1):985. doi: 10.1186/s12889-025-22193-6.
3
Global, regional, and national trends in peripheral arterial disease among older adults: findings from the global burden of disease study 2021.老年人外周动脉疾病的全球、区域和国家趋势:2021年全球疾病负担研究的结果
Aging Clin Exp Res. 2025 May 13;37(1):150. doi: 10.1007/s40520-025-03037-0.
4
Global burden of stroke in adolescents and young adults (aged 15-39 years) from 1990 to 2019: a comprehensive trend analysis based on the global burden of disease study 2019.全球范围内 1990 年至 2019 年青少年和青年(15-39 岁)人群中卒中的负担:基于 2019 年全球疾病负担研究的全面趋势分析。
BMC Public Health. 2024 Jul 30;24(1):2042. doi: 10.1186/s12889-024-19551-1.
5
Global trends and regional differences in disease burden of stroke among children: a trend analysis based on the global burden of disease study 2019.全球儿童卒中疾病负担的趋势和区域差异:基于 2019 年全球疾病负担研究的趋势分析。
BMC Public Health. 2023 Oct 27;23(1):2120. doi: 10.1186/s12889-023-17046-z.
6
Global, regional and national burden and trends of larynx cancer among adults aged 55 and older from 1990 to 2021: results from the global burden of disease study 2021.1990年至2021年55岁及以上成年人喉癌的全球、区域和国家负担及趋势:全球疾病负担研究2021的结果
BMC Public Health. 2025 Mar 6;25(1):906. doi: 10.1186/s12889-025-21993-0.
7
Global, regional, and national burden of ischaemic heart disease and its trends, 1990-2019.全球、区域和国家缺血性心脏病负担及其趋势,1990-2019 年。
Public Health. 2023 Oct;223:57-66. doi: 10.1016/j.puhe.2023.07.010. Epub 2023 Aug 19.
8
Global burden of rheumatoid arthritis among adolescents and young adults aged 10-24 years: A trend analysis study from 1990 to 2019.全球 10-24 岁青少年和年轻成年人类风湿性关节炎负担:1990 年至 2019 年的趋势分析研究。
PLoS One. 2024 Apr 16;19(4):e0302140. doi: 10.1371/journal.pone.0302140. eCollection 2024.
9
Global, regional, and national burdens of HIV and other sexually transmitted infections in adolescents and young adults aged 10-24 years from 1990 to 2019: a trend analysis based on the Global Burden of Disease Study 2019.全球、区域和国家青少年和年轻成年人(10-24 岁)艾滋病毒和其他性传播感染的负担:基于 2019 年全球疾病负担研究的趋势分析。
Lancet Child Adolesc Health. 2022 Nov;6(11):763-776. doi: 10.1016/S2352-4642(22)00219-X. Epub 2022 Sep 13.
10
The burden and trend prediction of ischemic heart disease associated with lead exposure: Insights from the Global Burden of Disease study 2021.铅暴露相关缺血性心脏病的负担及趋势预测:来自《2021年全球疾病负担研究》的见解
Environ Health. 2025 Apr 22;24(1):23. doi: 10.1186/s12940-025-01155-w.

引用本文的文献

1
Improving cardiovascular risk stratification: the role of abdominal obesity in predicting MACEs.改善心血管风险分层:腹型肥胖在预测主要不良心血管事件中的作用。
Cardiovasc Diabetol. 2025 Aug 11;24(1):328. doi: 10.1186/s12933-025-02885-4.
2
Inflammatory indices AISI and SIRI in atherosclerosis risk stratification: validation across community and intensive care populations.炎症指标AISI和SIRI在动脉粥样硬化风险分层中的作用:在社区和重症监护人群中的验证
Ann Med. 2025 Dec;57(1):2530792. doi: 10.1080/07853890.2025.2530792. Epub 2025 Jul 13.
3
The epidemiology and burden of atherosclerotic cardiovascular disease in China from 1990 to 2021: findings from the global burden of disease 2021.

本文引用的文献

1
Ideal cardiovascular health and mortality: pooled results of three prospective cohorts in Chinese adults.理想心血管健康与死亡率:中国成年人三项前瞻性队列研究的汇总结果。
Chin Med J (Engl). 2023 Jan 20;136(2):141-149. doi: 10.1097/CM9.0000000000002379.
2
Prioritization of intervention domains to prevent cardiovascular disease: a country-level case study using global burden of disease and local data.优先考虑干预领域以预防心血管疾病:使用全球疾病负担和本地数据进行的国家级案例研究。
Popul Health Metr. 2023 Jan 26;21(1):1. doi: 10.1186/s12963-023-00301-1.
3
Temporal trend in mortality of cardiovascular diseases and its contribution to life expectancy increase in China, 2013 to 2018.
1990年至2021年中国动脉粥样硬化性心血管疾病的流行病学及负担:全球疾病负担研究2021的结果
Front Public Health. 2025 Jun 26;13:1529506. doi: 10.3389/fpubh.2025.1529506. eCollection 2025.
4
Mechanism of Neutrophil p90RSK-Nrf2 Signaling Pathway in Atherosclerosis.中性粒细胞p90RSK-Nrf2信号通路在动脉粥样硬化中的作用机制
Balkan Med J. 2025 Jul 1;42(4):347-357. doi: 10.4274/balkanmedj.galenos.2025.2025-4-73.
5
A trend analysis of the burden of lower extremity peripheral arterial disease in China, 1990 to 2021: based on the Global Burden of Disease Study 2021.1990年至2021年中国下肢外周动脉疾病负担的趋势分析:基于《2021年全球疾病负担研究》
Front Public Health. 2025 Jun 19;13:1506748. doi: 10.3389/fpubh.2025.1506748. eCollection 2025.
6
Global burden of atherosclerotic cardiovascular disease attributed to lifestyle and metabolic risks.归因于生活方式和代谢风险的动脉粥样硬化性心血管疾病的全球负担。
Sci China Life Sci. 2025 Jun 23. doi: 10.1007/s11427-025-2948-y.
7
The Impact of Triglyceride-Glucose Index on Carotid Atherosclerosis: A Prospective Cohort Study in Middle Aged and Elderly Low-Income in Rural Chinese.甘油三酯-葡萄糖指数对颈动脉粥样硬化的影响:一项针对中国农村中老年低收入人群的前瞻性队列研究
Risk Manag Healthc Policy. 2025 Jun 17;18:1979-1990. doi: 10.2147/RMHP.S522995. eCollection 2025.
8
The correlation of perirenal fat and atherosclerosis: A systematic review and meta-analysis.肾周脂肪与动脉粥样硬化的相关性:一项系统评价和荟萃分析。
Sci Prog. 2025 Apr-Jun;108(2):368504251346566. doi: 10.1177/00368504251346566. Epub 2025 Jun 4.
9
Bioinformatics analysis to investigate the potential relationship between mitochondrial structure and function-related genes and the immune microenvironment in atherosclerosis.生物信息学分析以研究线粒体结构和功能相关基因与动脉粥样硬化免疫微环境之间的潜在关系。
Front Cardiovasc Med. 2025 May 13;12:1526151. doi: 10.3389/fcvm.2025.1526151. eCollection 2025.
10
Biopolymers of Polycaprolactone Loaded with Caffeic Acid and Extract Induced Proliferation in Human Coronary Artery Endothelial Cells and Inhibited Platelet Activity.负载咖啡酸和提取物的聚己内酯生物聚合物可诱导人冠状动脉内皮细胞增殖并抑制血小板活性。
Int J Mol Sci. 2025 May 21;26(10):4949. doi: 10.3390/ijms26104949.
2013 年至 2018 年中国心血管疾病死亡率的时间趋势及其对预期寿命增长的贡献。
Chin Med J (Engl). 2022 Sep 5;135(17):2066-2075. doi: 10.1097/CM9.0000000000002082.
4
Global, Regional, and National Burden of Ischemic Stroke, 1990-2019.全球、区域和国家缺血性脑卒中负担,1990-2019 年。
Neurology. 2022 Jan 18;98(3):e279-e290. doi: 10.1212/WNL.0000000000013115. Epub 2021 Dec 15.
5
[Trends of a burden on atherosclerotic cardiovascular disease and its related risk factors in China, 1990 to 2019].[1990年至2019年中国动脉粥样硬化性心血管疾病负担及其相关危险因素的趋势]
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1797-1803. doi: 10.3760/cma.j.cn112338-20201208-01390.
6
Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.1990—2019年全球、区域和国家的卒中负担及其风险因素:全球疾病负担研究2019的系统分析
Lancet Neurol. 2021 Oct;20(10):795-820. doi: 10.1016/S1474-4422(21)00252-0. Epub 2021 Sep 3.
7
Global burden of cardiovascular diseases attributable to hypertension in young adults from 1990 to 2019.2019 年全球归因于成年人高血压的心血管疾病负担。
J Hypertens. 2021 Dec 1;39(12):2488-2496. doi: 10.1097/HJH.0000000000002958.
8
Epidemiology of Peripheral Artery Disease and Polyvascular Disease.外周动脉疾病和多血管疾病的流行病学。
Circ Res. 2021 Jun 11;128(12):1818-1832. doi: 10.1161/CIRCRESAHA.121.318535. Epub 2021 Jun 10.
9
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
10
Primary prevention of ischaemic heart disease: populations, individuals, and health professionals.缺血性心脏病的一级预防:人群、个体和卫生专业人员。
Lancet. 2019 Aug 24;394(10199):685-696. doi: 10.1016/S0140-6736(19)31893-8.